Education
About Us
Working with TipRanks
Follow Us
Ridgetech (RDGT)
NASDAQ:RDGT
Top Page
Ridgetech
(NASDAQ:RDGT)
Rating:40Underperform
Price Target:―
Ridgetech (RDGT) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$6.02M
Dividend YieldN/A
Average Volume (3M)16.91K
Price to Earnings (P/E)―
Beta (1Y)0.39
Revenue Growth-4.87%
EPS Growth94.14%
CountryUS
Employees939
SectorHealthcare
Sector Strength39
IndustryMedical - Distribution
Share Statistics
EPS (TTM)-2.32
Shares Outstanding6,178,362
10 Day Avg. Volume6,540
30 Day Avg. Volume16,905
Financial Highlights & Ratios
PEG Ratio-0.13
Price to Book (P/B)0.34
Price to Sales (P/S)0.00
P/FCF Ratio-0.38
Enterprise Value/Market Cap4.78
Enterprise Value/Revenue0.05
Enterprise Value/Gross Profit0.93
Enterprise Value/Ebitda-0.55
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Ridgetech Business Overview & Revenue Model
Company DescriptionRidgetech Inc operates as a holding company. The Company, through its subsidiaries, wholesales, distributes, and retails pharmaceutical and other healthcare products.
How the Company Makes MoneyChina Jo-Jo Drugstores generates revenue through multiple channels. The core of its revenue model is derived from the sale of pharmaceutical products and healthcare items through its retail pharmacy outlets. The company also engages in wholesale distribution, supplying drugs to hospitals, clinics, and other pharmacies. Additionally, CJJD leverages e-commerce platforms to reach a broader customer base, providing an online sales channel for its products. Key partnerships with suppliers and manufacturers ensure a steady inventory of high-demand items, further supporting its revenue streams.
Ridgetech Financial Statement Overview
Summary
Income Statement
Balance Sheet
Cash Flow
| Breakdown | ||||
| Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|
| Income Statement | Total Revenue | |||
| 154.54M | 148.81M | 164.39M | 133.13M | 117.33M |
| Gross Profit | ||||
| 31.11M | 34.28M | 36.52M | 29.24M | 25.53M |
| EBIT | ||||
| -3.53M | -10.57M | -2.55M | -8.61M | -6.38M |
| EBITDA | ||||
| 1.23M | -19.96M | -579.93K | -6.08M | -3.66M |
| Net Income Common Stockholders | ||||
| -4.23M | -21.14M | -3.20M | -8.38M | -6.46M |
| Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
| 20.15M | 18.81M | 18.55M | 22.14M | 16.33M |
| Total Assets | ||||
| 95.06M | 90.97M | 106.38M | 106.31M | 99.52M |
| Total Debt | ||||
| 43.22M | 42.16M | 48.67M | 46.78M | 54.45M |
| Net Debt | ||||
| 23.07M | 23.35M | 30.22M | 24.74M | 38.27M |
| Total Liabilities | ||||
| 80.76M | 74.30M | 83.65M | 81.91M | 80.74M |
| Stockholders Equity | ||||
| 15.64M | 18.01M | 24.09M | 25.74M | 20.59M |
| Cash Flow | Free Cash Flow | |||
| -4.08M | -3.60M | -5.69M | -666.47K | -9.19M |
| Operating Cash Flow | ||||
| -3.16M | -3.28M | -5.39M | -62.29K | -6.91M |
| Investing Cash Flow | ||||
| -2.04M | -316.10K | -306.14K | -2.00M | -4.84M |
| Financing Cash Flow | ||||
| 8.00M | 2.37M | 4.84M | 3.08M | 19.01M |
Ridgetech Technical Analysis
Negative
0.98
Price Trends
1.03
Negative
1.22
Negative
1.56
Negative
Market Momentum
-0.02
Positive
41.96
Neutral
13.33
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For RDGT, the sentiment is Negative. The current price of 0.98 is below the 20-day moving average (MA) of 1.03, below the 50-day MA of 1.03, and below the 200-day MA of 1.56, indicating a bearish trend. The MACD of -0.02 indicates Positive momentum. The RSI at 41.96 is Neutral, neither overbought nor oversold. The STOCH value of 13.33 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for RDGT.
Ridgetech Risk Analysis
Ridgetech disclosed 58 risk factors in its most recent earnings report. Ridgetech reported the most risks in the “Legal & Regulatory” category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 1 New Risks
1.
HJ Group is subject to restrictions on making payments to us. Q1, 2023
Ridgetech Peers Comparison
Overall Rating
UnderperformOutperform
Sector (53)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
53 Neutral | $5.23B | 3.23 | -44.27% | 2.82% | 16.82% | 0.11% | |
50 Neutral | $60.35M | ― | -2.28% | ― | 64.34% | 70.95% | |
47 Neutral | $15.86M | 1.85 | -23.21% | ― | ― | ― | |
41 Neutral | $61.08M | 24.14 | -27.52% | ― | -8.63% | -202.31% | |
40 Underperform | $6.02M | ― | -27.69% | ― | -4.87% | 94.14% |
* Healthcare Sector Average
Performance Comparison
RDGT
Ridgetech
0.96
-1.59
-62.35%
GEG
Great Elm Group
2.15
0.41
23.56%
ZYXI
Zynex
2.14
-7.50
-77.80%
SNYR
Synergy CHC
2.07
1.95
1625.00%
Glossary
OutperformA stock rated as "Outperform" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock is likely to deliver higher returns compared to the average returns of other stocks in the same sector or market index. Investors might consider this stock a good buying opportunity.
NeutralA stock rated as "Neutral" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly attractive nor unattractive for investment. Investors may consider holding onto the stock, as it is not expected to either significantly outperform or underperform the market.
UnderperformA stock rated as "Underperform" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests that the stock may deliver lower returns compared to the average returns of other stocks in the same sector or market index. Investors might consider selling the stock or avoiding it as an investment.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.